{
    "title": "U.S. FDA panel votes against Amylyx's ALS drug over trial data concerns",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10670079/U-S-FDA-panel-votes-against-Amylyxs-ALS-drug-trial-data-concerns.html",
    "date": "2022-03-30",
    "keywords": [
        "drug",
        "trial",
        "disease",
        "decision",
        "panel",
        "study",
        "amylyx",
        "reporting",
        "march",
        "food",
        "administration",
        "sclerosis",
        "committee",
        "amx0035",
        "companys",
        "submission",
        "response",
        "treatment",
        "option",
        "cause",
        "brain",
        "cord",
        "function",
        "disability",
        "death",
        "lou",
        "spotlight",
        "ice",
        "bucket",
        "challenge",
        "water",
        "june",
        "agency",
        "line",
        "monday",
        "staff",
        "efficacy",
        "evidence",
        "persuasiveness",
        "robustness",
        "doesnt",
        "bar",
        "fischbeck",
        "investigator",
        "institutes",
        "health",
        "vote",
        "contrast",
        "support",
        "hearing",
        "patient",
        "mark",
        "weston",
        "harm",
        "completion",
        "leo",
        "roy",
        "anilkumar",
        "editing",
        "shinjini",
        "ganguli",
        "syamnath",
        "rashmi",
        "aich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}